Quick Answer
BioCardia, Inc. reported Operating Income Loss of -$8.28 million for the year ending 2025.
- BioCardia, Inc. showed a decrease of -3.5% in Operating Income Loss from 2024 to 2025.
- This data is from BioCardia, Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: -$139.0 thousand | Q1 2011: -$101.0 thousand | Q2 2011: -$249.0 thousand | Q3 2011: -$110.0 thousand | Q1 2012: -$58.0 thousand | Q2 2012: -$132.0 thousand | Q3 2012: -$83.0 thousand | Q1 2013: -$26.0 thousand | Q2 2013: $6.0 thousand | Q3 2013: $26.0 thousand | Q1 2014: $63.0 thousand | Q2 2014: $65.0 thousand | Q3 2014: $42.0 thousand | Q1 2015: $75.0 thousand | Q2 2015: $72.0 thousand | Q3 2015: $83.0 thousand | Q1 2016: -$1.08 million | Q2 2016: -$1.38 million | Q3 2016: -$1.68 million | Q1 2017: -$2.88 million | Q2 2017: -$2.97 million | Q3 2017: -$3.04 million | Q1 2018: -$3.62 million | Q2 2018: -$3.25 million | Q3 2018: -$3.57 million | Q1 2019: -$3.69 million | Q2 2019: -$3.76 million | Q3 2019: -$3.23 million | Q1 2020: -$4.61 million | Q2 2020: -$3.57 million | Q3 2020: -$3.85 million | Q1 2021: -$2.97 million | Q2 2021: -$3.49 million | Q3 2021: -$2.71 million | Q1 2022: -$3.33 million | Q2 2022: -$2.50 million | Q3 2022: -$3.06 million | Q1 2023: -$3.51 million | Q2 2023: -$3.45 million | Q3 2023: -$2.60 million | Q1 2024: -$2.28 million | Q2 2024: -$1.65 million | Q3 2024: -$1.76 million | Q1 2025: -$2.73 million | Q2 2025: -$2.05 million | Q3 2025: -$1.49 million.
- Over the full 16 years of available data (2010 to 2025), BioCardia, Inc.'s Operating Income Loss has declined by 1,319.9%.
- Historical annual values: Fiscal year 2025: -$8.28 million | Fiscal year 2024: -$8.00 million | Fiscal year 2023: -$11.64 million | Fiscal year 2022: -$11.90 million | Fiscal year 2021: -$12.63 million | Fiscal year 2020: -$15.53 million | Fiscal year 2019: -$14.21 million | Fiscal year 2018: -$14.10 million | Fiscal year 2017: -$12.41 million | Fiscal year 2016: -$7.61 million | Fiscal year 2015: -$5.41 million | Fiscal year 2014: $231.0 thousand | Fiscal year 2013: $9.0 thousand | Fiscal year 2012: -$339.0 thousand | Fiscal year 2011: -$618.0 thousand | Fiscal year 2010: -$583.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: